156 related articles for article (PubMed ID: 19307596)
21. Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria.
Feng J; Lucchinetti E; Enkavi G; Wang Y; Gehrig P; Roschitzki B; Schaub MC; Tajkhorshid E; Zaugg K; Zaugg M
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C740-8. PubMed ID: 20007455
[TBL] [Abstract][Full Text] [Related]
22. Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.
Wang J; Li S; Zhang X; Zhu N; Yiminniyaze R; Dong L; Li C; Gulinuer W; Xia J; Li J; Zhou D; Liu X; Zhang Y; Zhang Y; Li S
Thorac Cancer; 2022 Nov; 13(21):3042-3051. PubMed ID: 36193770
[TBL] [Abstract][Full Text] [Related]
23. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of Hic-5 at tyrosine 60 by CAKbeta and Fyn.
Ishino M; Aoto H; Sasaski H; Suzuki R; Sasaki T
FEBS Lett; 2000 Jun; 474(2-3):179-83. PubMed ID: 10838081
[TBL] [Abstract][Full Text] [Related]
25. Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells.
Hirsch CL; Smith-Windsor EL; Bonham K
Int J Cancer; 2006 Feb; 118(3):547-54. PubMed ID: 16094635
[TBL] [Abstract][Full Text] [Related]
26. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
Liu H; Qiu J; Li N; Chen T; Cao X
J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-27b suppresses tumor progression by regulating ARFGEF1 and focal adhesion signaling.
Matsuyama R; Okuzaki D; Okada M; Oneyama C
Cancer Sci; 2016 Jan; 107(1):28-35. PubMed ID: 26473412
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib.
Serrels A; Macpherson IR; Evans TR; Lee FY; Clark EA; Sansom OJ; Ashton GH; Frame MC; Brunton VG
Mol Cancer Ther; 2006 Dec; 5(12):3014-22. PubMed ID: 17148760
[TBL] [Abstract][Full Text] [Related]
29. Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src‑mediated phosphorylation of EGF receptor tyrosine kinase.
Kundu J; Choi BY; Jeong CH; Kundu JK; Chun KS
Oncol Rep; 2014 Aug; 32(2):821-8. PubMed ID: 24890449
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation.
Yang K; Kim JH; Kim HJ; Park IS; Kim IY; Yang BS
J Biol Chem; 2005 Nov; 280(47):39058-66. PubMed ID: 16186108
[TBL] [Abstract][Full Text] [Related]
31. Novel β-phenylacrylic acid derivatives exert anti-cancer activity by inducing Src-mediated apoptosis in wild-type KRAS colon cancer.
Kim SJ; Noh TH; Son S; Kim DH; Kim W; Lee Y; Choo J; Heo G; Kim MJ; Chung HY; Jung Y; Jung JH; Moon HR; Im E
Cell Death Dis; 2018 Aug; 9(9):877. PubMed ID: 30158525
[TBL] [Abstract][Full Text] [Related]
32. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
33. Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression.
Oneyama C; Yoshikawa Y; Ninomiya Y; Iino T; Tsukita S; Okada M
Oncogene; 2016 Jan; 35(4):501-12. PubMed ID: 25867068
[TBL] [Abstract][Full Text] [Related]
34. [Role of PDLIM4 and c-Src in Breast Cancer Progression].
Kravchenko DS; Frolova EI; Kravchenko JE; Chumakov SP
Mol Biol (Mosk); 2016; 50(1):69-79. PubMed ID: 27028812
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer.
Zhou J; Scholes J; Hsieh JT
J Biol Chem; 2003 Feb; 278(9):6936-41. PubMed ID: 12473651
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation-dependent and phosphorylation-independent modes of modulation of shaker family voltage-gated potassium channels by SRC family protein tyrosine kinases.
Nitabach MN; Llamas DA; Thompson IJ; Collins KA; Holmes TC
J Neurosci; 2002 Sep; 22(18):7913-22. PubMed ID: 12223544
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.
Poghosyan Z; Robbins SM; Houslay MD; Webster A; Murphy G; Edwards DR
J Biol Chem; 2002 Feb; 277(7):4999-5007. PubMed ID: 11741929
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of IRE1ɑ suppresses metastatic potential of colon cancer cells through inhibiting FN1-Src/FAK-GTPases signaling.
Xie Y; Liu C; Qin Y; Chen J; Fang J
Int J Biochem Cell Biol; 2019 Sep; 114():105572. PubMed ID: 31326465
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression.
Huang WC; Chen JJ; Inoue H; Chen CC
J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358
[TBL] [Abstract][Full Text] [Related]
40. Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress.
Kopetz S; Lesslie DP; Dallas NA; Park SI; Johnson M; Parikh NU; Kim MP; Abbruzzese JL; Ellis LM; Chandra J; Gallick GE
Cancer Res; 2009 May; 69(9):3842-9. PubMed ID: 19383922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
